15 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Medtronic (MDT) Suffers a Larger Drop Than the General Market: Key Insights https://www.zacks.com/stock/news/2221357/medtronic-mdt-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2221357 Feb 05, 2024 - Medtronic (MDT) concluded the recent trading session at $86.75, signifying a -1% move from its prior day's close.
What's in the Cards for Medtronic (MDT) in Q3 Earnings? https://www.zacks.com/stock/news/2224881/what-s-in-the-cards-for-medtronic-mdt-in-q3-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2224881 Feb 12, 2024 - Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal third-quarter performance.
Medtronic (MDT) Advances But Underperforms Market: Key Facts https://www.zacks.com/stock/news/2226424/medtronic-mdt-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2226424 Feb 14, 2024 - In the latest trading session, Medtronic (MDT) closed at $83.68, marking a +0.11% move from the previous day.
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769 Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
Medtronic's (MDT) MiniMed 780G System Study Data Favorable https://www.zacks.com/stock/news/2238698/medtronic-s-mdt-minimed-780g-system-study-data-favorable?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238698 Mar 11, 2024 - Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola https://www.zacks.com/commentary/2256168/q1-earnings-scorecard-and-analyst-reports-for-mastercard-netflix-coca-cola?cid=CS-ZC-FT-research_daily-2256168 Apr 16, 2024 - Today's Research Daily features a real-time update on the Q1 earnings season and new research reports Mastercard (MA), Netflix (NFLX) and Coke (KO) and others.
2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now https://www.fool.com/investing/2024/01/28/2-high-yield-healthcare-stocks-to-buy-with-both-ha/?source=iedfolrf0000001 Jan 28, 2024 - All three of these stocks offer attractive dividend yields, but one looks risky.
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors https://www.zacks.com/stock/news/2223695/medtronic-mdt-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2223695 Feb 08, 2024 - In the closing of the recent trading day, Medtronic (MDT) stood at $86.18, denoting a -1.12% change from the preceding trading day.
Medtronic (MDT) Q3 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/02/20/medtronic-mdt-q3-2024-earnings-call-transcript/?source=iedfolrf0000001 Feb 20, 2024 - MDT earnings call for the period ending December 31, 2023.
MDT vs. LMAT: Which Stock Should Value Investors Buy Now? https://www.zacks.com/stock/news/2229499/mdt-vs-lmat-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2229499 Feb 21, 2024 - MDT vs. LMAT: Which Stock Is the Better Value Option?

Pages: 12

Page 1